Ben Z Katz1, Caroline Reuter2, Yair Lupovitch3, Kristen Gleason4, Damani McClellan4, Joseph Cotler4, Leonard A Jason4. 1. Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL; Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL. Electronic address: bkatz@northwestern.edu. 2. Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL. 3. Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL. 4. Center for Community Research, DePaul University, Chicago, IL.
Abstract
OBJECTIVES: To develop a scale for the severity of mononucleosis. STUDY DESIGN: One to 5 percent of college students develop infectious mononucleosis annually, and about 10% meet criteria for chronic fatigue syndrome (CFS) 6 months following infectious mononucleosis. We developed a severity of mononucleosis scale based on a review of the literature. College students were enrolled, generally when they were healthy. When the students developed infectious mononucleosis, an assessment was made as to the severity of their infectious mononucleosis independently by 2 physicians using the severity of mononucleosis scale. This scale was correlated with corticosteroid use and hospitalization. Six months following infectious mononucleosis, an assessment is made for recovery from infectious mononucleosis or meeting 1 or more case definitions of CFS. RESULTS: In total, 126 severity of mononucleosis scales were analyzed. The concordance between the 2 physician reviewers was 95%. All 3 hospitalized subjects had severity of mononucleosis scores ≥2. Subjects with severity of mononucleosis scores of ≥1 were 1.83 times as likely to be given corticosteroids. Students with severity of mononucleosis scores of 0 or 1 were less likely to meet more than 1 case definition of CFS 6 months following infectious mononucleosis. CONCLUSIONS: The severity of mononucleosis scale has interobserver, concurrent and predictive validity for hospitalization, corticosteroid use, and meeting criteria for CFS 6 months following infectious mononucleosis.
OBJECTIVES: To develop a scale for the severity of mononucleosis. STUDY DESIGN: One to 5 percent of college students develop infectious mononucleosis annually, and about 10% meet criteria for chronic fatigue syndrome (CFS) 6 months following infectious mononucleosis. We developed a severity of mononucleosis scale based on a review of the literature. College students were enrolled, generally when they were healthy. When the students developed infectious mononucleosis, an assessment was made as to the severity of their infectious mononucleosis independently by 2 physicians using the severity of mononucleosis scale. This scale was correlated with corticosteroid use and hospitalization. Six months following infectious mononucleosis, an assessment is made for recovery from infectious mononucleosis or meeting 1 or more case definitions of CFS. RESULTS: In total, 126 severity of mononucleosis scales were analyzed. The concordance between the 2 physician reviewers was 95%. All 3 hospitalized subjects had severity of mononucleosis scores ≥2. Subjects with severity of mononucleosis scores of ≥1 were 1.83 times as likely to be given corticosteroids. Students with severity of mononucleosis scores of 0 or 1 were less likely to meet more than 1 case definition of CFS 6 months following infectious mononucleosis. CONCLUSIONS: The severity of mononucleosis scale has interobserver, concurrent and predictive validity for hospitalization, corticosteroid use, and meeting criteria for CFS 6 months following infectious mononucleosis.
Authors: Henry H Balfour; Carol J Holman; Kristin M Hokanson; Meghan M Lelonek; Jill E Giesbrecht; Dana R White; David O Schmeling; Chiu-Ho Webb; Winston Cavert; David H Wang; Richard C Brundage Journal: J Infect Dis Date: 2005-09-26 Impact factor: 5.226
Authors: Ian Hickie; Tracey Davenport; Denis Wakefield; Ute Vollmer-Conna; Barbara Cameron; Suzanne D Vernon; William C Reeves; Andrew Lloyd Journal: BMJ Date: 2006-09-01
Authors: Pierre Tattevin; Yves Le Tulzo; Sophie Minjolle; Arnaud Person; Jean Marc Chapplain; Cedric Arvieux; Remi Thomas; Christian Michelet Journal: J Clin Microbiol Date: 2006-05 Impact factor: 5.948
Authors: Leonard A Jason; Joseph Cotler; Mohammed F Islam; Madison Sunnquist; Ben Z Katz Journal: Clin Infect Dis Date: 2021-12-06 Impact factor: 9.079